209 results
8-K
EX-4.2
zar1 0n11e5w
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
EX-4.1
g80l6 fsuyib19pml5v
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
EX-99.1
py4ltooosq1 m5b7tga
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
UPLOAD
da3p8yvyyupk
3 Nov 23
Letter from SEC
12:00am
8-K
EX-4.2
f9ny6y9p94
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-10.1
xi44 yd8b
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
tyj ivuwv
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
n0ad8idqz8y16i
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
m8m6f3pluzqbgmp
2 Oct 23
Prospectus supplement for primary offering
4:52pm
424B5
skczdo u8h
21 Jul 23
Prospectus supplement for primary offering
4:39pm